Primary Site >> Colorectal Cancer
Gene >> IFNA1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Effects of fibroblast and recombinant leukocyte interferons and double-stranded RNA on ppp(2'-5')An synthesis and cell proliferation in human colon carcinoma cells in vitro. PMID: 6189584 |
Ref: Treatment of patients with disseminated colorectal cancer with recombinant human alpha 2-interferon. Studies on the immune system. PMID: 6229496 Ref: Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. PMID: 6744259 |
Ref: Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. PMID: 3918869 Ref: HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. PMID: 3923246 Ref: Leukocyte adherence inhibition, natural killer cell activity, gamma-interferon production capacity and phytohemagglutinin response in patients treated with recombinant leukocyte A interferon. PMID: 3923413 |
Ref: Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients. PMID: 3091371 Ref: [Experimental and clinical studies on chemosensitivity tests of anticancer agents by human tumor clonogenic assay]. PMID: 3092023 |
Ref: [Combined effect of human recombinant interferon alpha, beta and gamma on tumor cell growth and the cell cycle in vitro]. PMID: 3107476 Ref: Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer. PMID: 3598328 Ref: Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines. PMID: 3828990 |
Ref: Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells. PMID: 2451894 Ref: Interferon-gamma activates the voltage-gated calcium channel in RPMI 4788 cells. PMID: 2455515 Ref: [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay]. PMID: 3136700 Ref: Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study. PMID: 3142836 Ref: Inhibition of mitogen stimulated growth of human colon cancer cells by interferon. PMID: 3166905 |
Ref: Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde. PMID: 2463072 Ref: Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. PMID: 2499665 Ref: Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model. PMID: 2910826 |
Ref: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. PMID: 1692761 Ref: Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. PMID: 1697499 Ref: Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma. PMID: 1704693 Ref: The effect of interferon treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro. PMID: 1707938 Ref: The clinical significance of interleukin-2. PMID: 2092277 Ref: Comparison of the replication of distinct strains of human coronavirus OC43 in organotypic human colon cells (Caco-2) and mouse intestine. PMID: 2103102 Ref: Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: alpha, beta, and gamma. PMID: 2138228 Ref: IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity. PMID: 2158515 Ref: A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma. PMID: 2386896 |
Ref: Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. PMID: 1673988 Ref: Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors. PMID: 1719644 Ref: Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression. PMID: 1825650 Ref: Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. PMID: 1893380 Ref: Rational basis for the metabolic modulation of 5-fluorouracil by leucovorin and interferon alpha. PMID: 1931710 Ref: Chemosensitivity and cytokine sensitivity of malignant mesothelioma. PMID: 1934246 |
Ref: Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma. PMID: 1389518 Ref: Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma. PMID: 1394039 Ref: Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients. PMID: 1498068 Ref: Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer. PMID: 1524906 Ref: Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells. PMID: 1540167 Ref: A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. PMID: 1553576 Ref: Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience. PMID: 1557642 Ref: A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. PMID: 1557647 Ref: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a. PMID: 1557648 Ref: Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer. PMID: 1557649 Ref: Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma. PMID: 1557650 Ref: Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer. PMID: 1557651 Ref: Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells. PMID: 1571334 Ref: High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratio. PMID: 1609456 |
Ref: The role of interferons in the treatment of colorectal cancer. PMID: 7693882 Ref: TNF alpha protects SW742 human colon carcinoma cells against non-MHC-restricted cytolysis. PMID: 7907319 Ref: Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules. PMID: 8100485 Ref: Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations. PMID: 8221681 Ref: [A case of pulmonary metastasis from colon cancer successfully treated by 5-FU combined with leucovorin and interferon alpha-2a]. PMID: 8239693 Ref: A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer. PMID: 8292812 Ref: Peri-operative modulation of cellular immunity in patients with colorectal cancer. PMID: 8403515 Ref: Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. PMID: 8418225 Ref: Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. PMID: 8448736 Ref: [Treatment of advanced gastric and colorectal cancer with 5-FU, leucovorin and interferon-alpha]. PMID: 8452387 Ref: Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience. PMID: 8453558 Ref: Mechanisms by which interferon potentiates chemotherapy. PMID: 8485653 Ref: Clinical and pharmacological studies of interferon and chemotherapy in gastrointestinal and breast cancer. PMID: 8509231 |
Ref: Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer. PMID: 7833131 Ref: Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. PMID: 7847809 Ref: The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer. PMID: 7947102 Ref: Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). PMID: 8186170 Ref: Induction by human interferon and murine h-2l(d) gene of the surface expression of endogenous hla class-I free heavy-chains in hct human colon-carcinoma cells, deficient in Beta-2-microglobulin. PMID: 21559573 |
Ref: Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer. PMID: 7600563 Ref: [Biomodulation of 5-fluorouracil by interferon]. PMID: 7611752 Ref: 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. PMID: 7627962 Ref: Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. PMID: 7642571 Ref: Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-alpha: an overview of clinical trials. PMID: 7646900 Ref: The correlation of thymidine phosphorylase activity with the expression of interleukin 1 alpha, interferon alpha and interferon gamma in human colorectal carcinoma. PMID: 7656244 Ref: Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer. PMID: 7666089 Ref: Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. PMID: 7736406 Ref: Subcutaneous interleukin-2 and alpha-interferon in advanced colorectal carcinoma. A phase II study. PMID: 7780487 Ref: Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma. PMID: 7786594 Ref: Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1. PMID: 7797233 Ref: Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid. PMID: 8542247 Ref: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft. PMID: 8572582 Ref: A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma. PMID: 8680653 |
Ref: Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine. PMID: 8694532 Ref: Combining 5-fluorouracil with interferon-alpha in the treatment of advanced colorectal cancer: optimism followed by disappointment. PMID: 8742096 Ref: Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. PMID: 8823494 Ref: A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. PMID: 8826868 Ref: A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma. PMID: 8862717 Ref: 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study. PMID: 8879370 Ref: Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292. PMID: 8931668 Ref: Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer. PMID: 8980407 |
Ref: A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma. PMID: 9020490 Ref: Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). PMID: 9070485 Ref: Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer. PMID: 9119749 Ref: Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. PMID: 9155534 Ref: Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292) PMID: 9327152 Ref: Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro. PMID: 9402106 Ref: Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells. PMID: 9815814 |
Ref: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study. PMID: 9461008 Ref: Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma. PMID: 9463483 Ref: Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. PMID: 9469324 Ref: Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells. PMID: 9537263 Ref: Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer. PMID: 9792144 Ref: Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. PMID: 9796963 Ref: Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma. PMID: 9823427 Ref: Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. PMID: 9839521 |
Ref: A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). PMID: 10023694 Ref: 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group. PMID: 10091727 Ref: Synergetic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells. PMID: 10202238 Ref: Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines. PMID: 10211790 Ref: Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. PMID: 10218462 Ref: Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer. PMID: 10339671 Ref: Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study. PMID: 10448286 Ref: Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. PMID: 10570189 Ref: Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer. PMID: 10606259 Ref: Influence of peri-operative immunotherapy on serum cytokines and soluble cytokine receptors in patients undergoing surgery for colorectal cancer. PMID: 23577850 |
Ref: Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. PMID: 10766192 Ref: Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. PMID: 10866311 Ref: Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. PMID: 10894967 Ref: Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. PMID: 10914738 Ref: Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12. PMID: 10916758 Ref: Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A. PMID: 11031784 |
Ref: Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression. PMID: 11167991 Ref: Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines. PMID: 11169257 |
Ref: Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. PMID: 12058282 Ref: Cancer immunotherapy: the interferon-alpha experience. PMID: 12068384 Ref: Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression. PMID: 12070711 Ref: [Report on the first year of the activity of the National Oncological RD Consortium]. PMID: 12563351 |
Ref: TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. PMID: 12761580 Ref: Optimal use of the combination of irinotecan and 5-fluorouracil. PMID: 12802797 Ref: Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. PMID: 12972432 Ref: Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma. PMID: 14669296 |
Ref: Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha. PMID: 14684586 Ref: Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. PMID: 15034082 Ref: Induction of p53-dependent apoptosis in HCT116 tumor cells by RNA viruses and possible implications in virus-mediated oncolysis. PMID: 15254403 Ref: Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. PMID: 15286803 |
Ref: Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. PMID: 15492751 Ref: Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction. PMID: 15772692 Ref: Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha. PMID: 16041207 Ref: Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. PMID: 16138001 Ref: The future development of bevacizumab in colorectal cancer. PMID: 16301834 Ref: Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin. PMID: 16317265 |
Ref: Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients. PMID: 16598674 Ref: Overview how adenocarcinoma cancer cells avoid immune- and chemotherapy-induced apoptosis. PMID: 17357275 |
Ref: Circadian rhythms in the CNS and peripheral clock disorders: chronopharmacological findings on antitumor drugs. PMID: 17299245 Ref: Thymosin alpha 1: from bench to bedside. PMID: 17600290 Ref: Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells. PMID: 17671689 Ref: IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells. PMID: 17786371 Ref: Retrospective comparison of two different schedules of irinotecan, 5-fluorouracil and folinic acid in previously untreated patients with advanced colorectal carcinoma: a single institution experience. PMID: 18230559 |
Ref: A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. PMID: 18494554 |
Ref: TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. PMID: 20367642 Ref: [A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes]. PMID: 21224654 |
Ref: Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients. PMID: 21371173 Ref: The effect of combining interferon-alpha and gefitinib in human colon cancer cell lines. PMID: 21942111 Ref: Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. PMID: 22201704 |
Ref: Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients. PMID: 20820907 Ref: A Semliki forest virus vector engineered to express IFNalpha induces efficient elimination of established tumors. PMID: 21734727 Ref: [Influence of interferon-alpha2a on thymidine phosphorylase expression and anticancer activity of 5'-deoxy-fluorouridine in human colon carcinoma cell lines LOVO and SW480]. PMID: 22851078 Ref: (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. PMID: 23741252 |
Ref: Addition of interferon-alpha to the p53-SLP(R) vaccine results in increased production of interferon-gamma in vaccinated colorectal cancer patients: a phase I/II clinical trial. PMID: 22948952 Ref: IFNalpha converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets. PMID: 23153456 Ref: Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers. PMID: 24100378 Ref: Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials. PMID: 24363758 |
Ref: [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice]. PMID: 24785276 Ref: Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species. PMID: 24792812 Ref: Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells. PMID: 25043256 Ref: Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival. PMID: 25350395 |
Ref: The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways. PMID: 26061044 |
Ref: Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. PMID: 26956047 Ref: Xenogeneic cell-based vaccine therapy for colorectal cancer: Safety, association of clinical effects with vaccine-induced immune responses. PMID: 27565847 Ref: Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells. PMID: 27799536 |
Ref: Astilbin from Engelhardtia chrysolepis enhances intestinal barrier functions in Caco-2 cell monolayers. PMID: 28327343 Ref: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. PMID: 28344808 Ref: Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. PMID: 28711499 Ref: A Blueprint to Advance Colorectal Cancer Immunotherapies. PMID: 29038296 |
Ref: Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. PMID: 30042763 Ref: Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients. PMID: 30284380 Ref: Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-beta signaling axis in paclitaxel-resistant colon cancer. PMID: 30387134 |